Inhibition of SMS1 has been proposed as a potential therapeutic approach in atherosclerosis, as SMS1-/- mice show a decreased atherosclerotic phenotype characterized by reduced atherosclerotic lesions in the entire aortas as well as decreased macrophage content in these lesions [180]. Here, SGMS1 is linked to atherosclerosis.